Calcium-Sensing Receptor Tumor Expression and Lethal Prostate Cancer Progression | Zendy

Thomas U. Ahearn | Zendy; Naïri Tchrakian | Zendy; Kathryn M. Wilson | Zendy; Rosina T. Lis | Zendy; Elizabeth Nuttall | Zendy; Howard D. Sesso | Zendy; Massimo Loda | Zendy; Edward L. Giovannucci | Zendy; Lorelei A. Mucci | Zendy; Stephen P. Finn | Zendy; Irene M. Shui | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Calcium-Sensing Receptor Tumor Expression and Lethal Prostate Cancer Progression

Author(s) -

Thomas U. Ahearn,

Naïri Tchrakian,

Kathryn M. Wilson,

Rosina T. Lis,

Elizabeth Nuttall,

Howard D. Sesso,

Massimo Loda,

Edward L. Giovannucci,

Lorelei A. Mucci,

Stephen P. Finn,

Irene M. Shui

Publication year - 2016

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2016-1082

Subject(s) - prostate cancer , medicine , calcitriol receptor , hazard ratio , cancer , oncology , prostate , tumor progression , immunohistochemistry , pca3 , metastasis , tissue microarray , biochemical recurrence , calcium sensing receptor , proportional hazards model , vitamin d and neurology , pathology , cancer research , confidence interval , prostatectomy , calcium , parathyroid hormone

Prostate cancer metastases preferentially target bone, and the calcium-sensing receptor (CaSR) may play a role in promoting this metastatic progression.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research